Role of Scaffold Proteins in Functional Alteration of Small Intestinal P-Glycoprotein by Anti-Cancer Drugs

Yakugaku Zasshi - Japan
doi 10.1248/yakushi.14-00234-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Limited Role of P-Glycoprotein in the Intestinal Absorption of Cyclosporin A

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2005English

Role of Intestinal P-Glycoprotein (Mdr1) in Interpatient Variation in the Oral Bioavailability of Cyclosporine*

Clinical Pharmacology and Therapeutics
Pharmacology
1997English

Changes in the Localization of Ileal P-Glycoprotein Induced by Intestinal Ischemia/Reperfusion

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2011English

A Water-Soluble Extract From Cultured Medium of Ganoderma Lucidum (Reishi) Mycelia Attenuates the Small Intestinal Injury Induced by Anti-Cancer Drugs

Oncology Letters
Cancer ResearchOncology
2010English

Role of P-Glycoprotein Inhibitors in Ceramide-Based Therapeutics for Treatment of Cancer

Biochemical Pharmacology
BiochemistryPharmacology
2017English

Methods of Identification of Drugs as P-Glycoprotein Substrates

I.P.Pavlov Russian Medical Biological Herald
2015English

New Potent P-Glycoprotein Inhibitors Carrying a Polycyclic Scaffold

English

Effects of Budesonide on P-Glycoprotein Expression in Intestinal Cell Lines

British Journal of Pharmacology
Pharmacology
2007English

Role of P-Glycoprotein in Transplacental Transfer of Methadone

Biochemical Pharmacology
BiochemistryPharmacology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy